A new hybrid strain has just been added to the menu! TAC: 24.52%, TOTAL THC: 22.8%, D9: 0.4%, THCA: 22.4%, CBG: 0.12%, CBGA: 1.6%, D-LIMONENE: 0.26%, BETA-CARYOPHYLLENE: 0.20% This strain is currently available in flower and pre-rolls.
The Medical Oversight Board for the Therapeutic Cannabis Program will be hosting a public hearing on the potential addition of “Autism Spectrum Disorder” to the list of qualifying conditions. The hearing will be held Wednesday, February 5th, 2020 from 4:00pm-5:30pm at The Department of Health and Human Services. 29 Hazen Drive, Concord N.H. Room 312 The written comment period will end the following Wednesday, February 12th, 2020. Written comments can be sent to firstname.lastname@example.org